Azalea Therapeutics, Inc.
PrivateLast Round
Series A
Nov 4, 2025
Total Funding Raised
$65M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Azalea Therapeutics, Inc. is a biotechnology company that develops Enveloped Delivery Vehicle (EDV) technology to enable precision in vivo genome engineering for cancer immunotherapies and other immune-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Azalea Therapeutics, Inc. Comparables
Compare Azalea Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbbVie | 73% | |
| CREATE Medicines | 70% | |
| Bristol Myers Squibb | 70% |
Azalea Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 4, 2025 |
Key People
Founding team and executive leadership
Azalea Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A |
| Yosemite | Series A |
| Sozo Ventures | Series A |
| Third Rock Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2026
Grew 33% QoQ, from 27 to 36 employees.
- Aug 31, 2026
Open roles increased to 9, 2.4x the trailing average.
Azalea Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Azalea Therapeutics, Inc.'s valuation, stock price, and market status.
Is Azalea Therapeutics, Inc. a public or private company?
Azalea Therapeutics, Inc. is a private company.
What is the current stock price of Azalea Therapeutics, Inc.?
Azalea Therapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Azalea Therapeutics, Inc. worth (valuation)?
Valuation information for Azalea Therapeutics, Inc. is not publicly available.
Can I buy Azalea Therapeutics, Inc. stock?
Azalea Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Azalea Therapeutics, Inc.'s last funding round?
Azalea Therapeutics, Inc.'s most recent funding round was Series A on November 4, 2025.
Who are the main investors in Azalea Therapeutics, Inc.?
Key investors in Azalea Therapeutics, Inc. include Third Rock Ventures.
Will Azalea Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Azalea Therapeutics, Inc..
How can I track Azalea Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Azalea Therapeutics, Inc.'s secondary market activity and sign up for updates.